Docket Number:13A-951212、13A-951214
Inventor:Hung Li
IP Status:US pending, TW pending, WO pending
Abstract:
This invention relates to compositions for treatment of spinal muscular atrophy (SMA) and methods for use thereof to treat SMA and other conditions of SMN-deficiency; novel drug development targets for SMA therapies, and methods of use thereof to screen for candidate therapeutic and diagnostic agents.
Fields of Application:
Treatment of spinal muscular atrophy (SMA)
Advantages when compared to the existing technologies:
There is no effecitve drug for spinal muscular atrophy (SMA).
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
